Arcturus Therapeutics Holdings Inc. - 8-K Filing

Arcturus Therapeutics secures $50 million equity investment and expanded collaboration with Meiji Seika Pharma Co., Ltd. (Items: 1.01 Entry into a Material Definitive Agreement, 3.02 Unregistered Sales of Equity Securities, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $ARCT

Read the full article at SEC EDGAR

More Regulatory news